PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.

Abstract When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available. NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, including seasonal and pandemic influenza viruses.These guidelines replace the 2007 Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions (https://stacks.cdc.gov/view/cdc/11425). Several elements remain unchanged from the 2007 guidance, which described recommended NPIs and the supporting rationale and key concepts for the use of these interventions during influenza pandemics. NPIs can be phased in, or layered, on the basis of pandemic severity and local transmission patterns over time. Categories of NPIs include personal protective measures for everyday use (e.g., voluntary home isolation of ill persons, respiratory etiquette, and hand hygiene); personal protective measures reserved for influenza pandemics (e.g., voluntary home quarantine of exposed household members and use of face masks in community settings when ill); community measures aimed at increasing social distancing (e.g., school closures and dismissals, social distancing in workplaces, and postponing or cancelling mass gatherings); and environmental measures (e.g., routine cleaning of frequently touched surfaces).Several new elements have been incorporated into the 2017 guidelines. First, to support updated recommendations on the use of NPIs, the latest scientific evidence available since the influenza A (H1N1)pdm09 pandemic has been added. Second, a summary of lessons learned from the 2009 H1N1 pandemic response is presented to underscore the importance of broad and flexible prepandemic planning. Third, a new section on community engagement has been included to highlight that the timely and effective use of NPIs depends on community acceptance and active participation. Fourth, to provide new or updated pandemic assessment and planning tools, the novel influenza virus pandemic intervals tool, the Influenza Risk Assessment Tool, the Pandemic Severity Assessment Framework, and a set of prepandemic planning scenarios are described. Finally, to facilitate implementation of the updated guidelines and to assist states and localities with prepandemic planning and decision-making, this report links to six supplemental prepandemic NPI planning guides for different community settings that are available online (https://www.cdc.gov/nonpharmaceutical-interventions).
PMID
Related Publications

Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic.

Knowledge, attitudes, and practices of nonpharmaceutical interventions following school dismissals during the 2009 Influenza A H1N1 pandemic in Michigan, United States.

Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.

Updated preparedness and response framework for influenza pandemics.

Public health emergency preparedness: lessons learned about monitoring of interventions from the National Association of County and City Health Official's survey of nonpharmaceutical interventions for pandemic H1N1.

Authors

Mayor MeshTerms
Keywords
Journal Title mmwr. recommendations and reports : morbidity and mortality weekly report. recommendations and reports
Publication Year Start




PMID- 28426646
OWN - NLM
STAT- In-Process
DA  - 20170420
LR  - 20170420
IS  - 1545-8601 (Electronic)
IS  - 1057-5987 (Linking)
VI  - 66
IP  - 1
DP  - 2017 Apr 21
TI  - Community Mitigation Guidelines to Prevent Pandemic Influenza - United States,
      2017.
PG  - 1-34
LID - 10.15585/mmwr.rr6601a1 [doi]
AB  - When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical
      interventions (NPIs) often are the most readily available interventions to help
      slow transmission of the virus in communities, which is especially important
      before a pandemic vaccine becomes widely available. NPIs, also known as community
      mitigation measures, are actions that persons and communities can take to help
      slow the spread of respiratory virus infections, including seasonal and pandemic 
      influenza viruses.These guidelines replace the 2007 Interim Pre-pandemic Planning
      Guidance: Community Strategy for Pandemic Influenza Mitigation in the United
      States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions
      (https://stacks.cdc.gov/view/cdc/11425). Several elements remain unchanged from
      the 2007 guidance, which described recommended NPIs and the supporting rationale 
      and key concepts for the use of these interventions during influenza pandemics.
      NPIs can be phased in, or layered, on the basis of pandemic severity and local
      transmission patterns over time. Categories of NPIs include personal protective
      measures for everyday use (e.g., voluntary home isolation of ill persons,
      respiratory etiquette, and hand hygiene); personal protective measures reserved
      for influenza pandemics (e.g., voluntary home quarantine of exposed household
      members and use of face masks in community settings when ill); community measures
      aimed at increasing social distancing (e.g., school closures and dismissals,
      social distancing in workplaces, and postponing or cancelling mass gatherings);
      and environmental measures (e.g., routine cleaning of frequently touched
      surfaces).Several new elements have been incorporated into the 2017 guidelines.
      First, to support updated recommendations on the use of NPIs, the latest
      scientific evidence available since the influenza A (H1N1)pdm09 pandemic has been
      added. Second, a summary of lessons learned from the 2009 H1N1 pandemic response 
      is presented to underscore the importance of broad and flexible prepandemic
      planning. Third, a new section on community engagement has been included to
      highlight that the timely and effective use of NPIs depends on community
      acceptance and active participation. Fourth, to provide new or updated pandemic
      assessment and planning tools, the novel influenza virus pandemic intervals tool,
      the Influenza Risk Assessment Tool, the Pandemic Severity Assessment Framework,
      and a set of prepandemic planning scenarios are described. Finally, to facilitate
      implementation of the updated guidelines and to assist states and localities with
      prepandemic planning and decision-making, this report links to six supplemental
      prepandemic NPI planning guides for different community settings that are
      available online (https://www.cdc.gov/nonpharmaceutical-interventions).
FAU - Qualls, Noreen
AU  - Qualls N
AD  - Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
FAU - Levitt, Alexandra
AU  - Levitt A
AD  - Office of Infectious Diseases, CDC, Atlanta, Georgia.
FAU - Kanade, Neha
AU  - Kanade N
AD  - Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
AD  - Eagle Medical Services, San Antonio, Texas.
FAU - Wright-Jegede, Narue
AU  - Wright-Jegede N
AD  - Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
AD  - Karna, Atlanta, Georgia.
FAU - Dopson, Stephanie
AU  - Dopson S
AD  - Division of State and Local Readiness, Office of Public Health Preparedness and
      Response, CDC, Atlanta, Georgia.
FAU - Biggerstaff, Matthew
AU  - Biggerstaff M
AD  - Influenza Division, National Center for Immunization and Respiratory Diseases,
      CDC, Atlanta, Georgia.
FAU - Reed, Carrie
AU  - Reed C
AD  - Influenza Division, National Center for Immunization and Respiratory Diseases,
      CDC, Atlanta, Georgia.
FAU - Uzicanin, Amra
AU  - Uzicanin A
AD  - Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
CN  - CDC Community Mitigation Guidelines Work Group
LA  - eng
PT  - Journal Article
DEP - 20170421
PL  - United States
TA  - MMWR Recomm Rep
JT  - MMWR. Recommendations and reports : Morbidity and mortality weekly report.
      Recommendations and reports
JID - 101124922
IR  - Levitt A
FIR - Levitt, Alexandra
IRAD- Office of Infectious Diseases, CDC.
IR  - Dopson S
FIR - Dopson, Stephanie
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - Frank M
FIR - Frank, Mark
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - Holloway R
FIR - Holloway, Rachel
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - Koonin L
FIR - Koonin, Lisa
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - Rasmussen S
FIR - Rasmussen, Sonja
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - Redd S
FIR - Redd, Stephen
IRAD- Influenza Coordination Unit, Office of Infectious Diseases, CDC.
IR  - de la Motte Hurst C
FIR - de la Motte Hurst, Christopher
IRAD- Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC.
IR  - Kanade N
FIR - Kanade, Neha
IRAD- Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC.
IR  - Qualls N
FIR - Qualls, Noreen
IRAD- Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC.
IR  - Rainey J
FIR - Rainey, Jeanette
IRAD- Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC.
IR  - Uzicanin A
FIR - Uzicanin, Amra
IRAD- Division of Global Migration and Quarantine, National Center for Emerging and
      Zoonotic Infectious Diseases, CDC.
IR  - Biggerstaff M
FIR - Biggerstaff, Matthew
IRAD- Influenza Division, National Center for Immunization and Respiratory Diseases,
      CDC.
IR  - Jernigan D
FIR - Jernigan, Daniel
IRAD- Influenza Division, National Center for Immunization and Respiratory Diseases,
      CDC.
IR  - Reed C
FIR - Reed, Carrie
IRAD- Influenza Division, National Center for Immunization and Respiratory Diseases,
      CDC.
EDAT- 2017/04/21 06:00
MHDA- 2017/04/21 06:00
CRDT- 2017/04/21 06:00
AID - 10.15585/mmwr.rr6601a1 [doi]
PST - epublish
SO  - MMWR Recomm Rep. 2017 Apr 21;66(1):1-34. doi: 10.15585/mmwr.rr6601a1.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>